Opaleye Management Inc. Bridge Bio Pharma, Inc. Transaction History

Opaleye Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $2.41 Million - $5.63 Million	-328,100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $2.09 Million - $9.8 Million	-183,400 Reduced 35.86%	328,100 $5.47 Million
Q3 2021 Nov 16, 2021	SELL	$46.87 - $64.24 $264,815 - $362,956	-5,650 Reduced 1.09%	511,500 $24 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $3.1 Million - $4.26 Million	-66,617 Reduced 11.41%	517,150 $31.5 Million
Q1 2021 May 18, 2021	BUY	$55.47 - $72.35 $32.4 Million - $42.2 Million	583,767 New	583,767 $36 Million

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.